VERNIERI, CLAUDIO

VERNIERI, CLAUDIO  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 36 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study 2017 C. VernieriA. MennittoF. de Braud + Article (author) -
Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters 2021 Infante, G.Vernieri, C. + Article (author) -
Association between the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and efficacy of CDK 4/6 inhibitors in advanced breast cancer: The observational multicenter Italian PALMARES study 2020 Zattarin, EFabbroni, CLigorio, FCorti, CBernocchi, OSirico, MCurigliano, GDe Braud, FGMVernieri, C + Article (author) -
Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders 2020 Vernieri C.Foiani M. + Article (author) -
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 2022 Zattarin, EmmaNichetti, FedericoLigorio, FrancescaMazzeo, LauraLobefaro, RiccardoFuca, GiovanniPeverelli, GiorgiaVingiani, Andreade Braud, FilippoVernieri, Claudio + Article (author) -
Cells Escape an Operational Mitotic Checkpoint through a Stochastic Process 2018 Bonaiuti, PaoloGross, FridolinCorno, AndreaVernieri, ClaudioCosentino Lagomarsino, Marco + Article (author) -
Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-l1 monoclonal antibodies 2019 Randon G.Vernieri C.de Braud F. + Article (author) -
Diet and supplements in cancer prevention and treatment : clinical evidences and future perspectives 2018 C. VernieriF. NichettiA. RaimondiF. de Braud + Article (author) -
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 2017 Vernieri, ClaudioVolpi, Chiara CostanzaNiger, MonicaValtorta, EmanueleFucà, GiovanniDi Bartolomeo, MariaDe Braud, FilippoPietrantonio, Filippo + Article (author) -
Endosomal trafficking and DNA damage checkpoint kinases dictate survival to replication stress by regulating amino acid uptake and protein synthesis 2021 Ajazi A.Manfrini N.Biffo S.Minucci S.Vernieri C.Foiani M. + Article (author) -
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma : the FAME Trial 2019 Vernieri, ClaudioGalli, GiuliaRizzo, Angela MariaCorsetto, Paola AntoniaPruneri, Giancarlode Braud, Filippo + Article (author) -
Heterogeneity of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer 2017 F. PietrantonioC. VernieriA. MennittoF. De Braud + Article (author) -
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications 2020 Zattarin, ELeporati, RLigorio, FLobefaro, RVingiani, APruneri, GVernieri, C Article (author) -
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies 2016 S. PuscedduF. De BraudC. VernieriA. Indini + Article (author) -
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 2021 Vernieri, ClaudioNichetti, FedericoMarra, AntonioRandon, GiovanniLigorio, FrancescaFerraro, EmanuelaTrapani, DarioMilani, AndreaBernocchi, OttaviaAjazi, ArtaGenerali, DanieleLosurdo, AgneseCurigliano, GiuseppePruneri, GiancarloMariani, Luigide Braud, Filippo + Article (author) -
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs) 2019 C. VernieriS. PuscedduG. FucàG. CentonzeL. CastagnoliE. FerrariA. AjaziM. FoianIV. MazzaferroG. PruneriF. de Braud + Article (author) -
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting 2018 De Braud, F.Fucà, G.Pietrantonio, F.Vernieri, C.Di Nicola, M. + Article (author) -
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC 2018 ZULATO, ELISABETTAF. de BraudC. Vernieri + Article (author) -
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. 2018 S. PuscedduC. VernieriS. MassironiF. CavalcoliV. MazzaferroF. de Braud + Article (author) -
Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes 2016 S. PuscedduC. VernieriV. MazzaferroF. De Braud + Article (author) -